FDA to look at study reclassifying youth suicide attempts while on antidepressants

06/20/2004 | NYTimes.com

FDA officials, under attack for rejecting analysis by one of its own experts concerning use of antidepressants in children, are looking at work by four Columbia University researchers studying reports of suspected suicide efforts by youngsters on antidepressants. The work involves reclassifying reports of suicide attempts based on a definition of what constitutes an attempt in an effort to clarify whether drugs may be the cause.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA